Signaling Pathway
Ntx1088 is a first-in-class, potent monoclonal antibody that targets the poliovirus receptor, also known as CD155. This antibody has demonstrated potential therapeutic applications in the treatment of patients with locally advanced and metastatic solid tumors. Its specific interaction with CD155 makes it a valuable tool for research and potential clinical use in oncology.
重要通知：仅供研究使用。我们不向患者销售。
| Discription | Ntx1088 is a first-in-class, potent monoclonal antibody that targets the poliovirus receptor, also known as CD155. This antibody has demonstrated potential therapeutic applications in the treatment of patients with locally advanced and metastatic solid tumors. Its specific interaction with CD155 makes it a valuable tool for research and potential clinical use in oncology. |
||
|---|---|---|---|
| Targets |
|
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2
